Mineralys Therapeutics
MLYS
MLYS
92 hedge funds and large institutions have $541M invested in Mineralys Therapeutics in 2024 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 24 increasing their positions, 34 reducing their positions, and 12 closing their positions.
Holders
92
Holders Change
+5
Holders Change %
+5.75%
% of All Funds
1.33%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
17
Increased
24
Reduced
34
Closed
12
Calls
$129K
Puts
$81K
Net Calls
+$48K
Net Calls Change
+$44K
Top Buyers
| 1 |
TCM
1
TCG Crossover Management
Palo Alto,
California
|
$41.1M |
| 2 |
O
2
OrbiMed
New York
|
$26.1M |
| 3 |
RCM
3
RA Capital Management
Boston,
Massachusetts
|
$62.6M |
| 4 |
SB
4
Samsara BioCapital
Palo Alto,
California
|
$65.5M |
| 5 |
VA
5
VR Adviser
New York
|
$7.17M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
SG Americas Securities
New York
| – | – | -10,093 | Closed |
|
|
GWS
102
Glassman Wealth Services
Vienna,
Virginia
| – | – | -372 | Closed |
|
|
PMEF
103
Point72 Middle East FZE
Dubai,
United Arab Emirates
| – | – | -135 | Closed |
|
104
Osaic Holdings
Scottsdale,
Arizona
| – | – | -77 | Closed |
|
|
CFGS
105
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|